Literature DB >> 14516872

Producing drugs from marine sponges.

El Hassan Belarbi1, Antonio Contreras Gómez, Yusuf Chisti, Francisco García Camacho, Emilio Molina Grima.   

Abstract

Marine sponges are potential sources of many unique metabolites, including cytotoxic and anticancer compounds. Natural sponge populations are insufficient or inaccessible for producing commercial quantities of metabolites of interest. This review focuses on methods of producing sponge biomass to overcome supply limitations. Production techniques discussed include aquaculture in the sea, the controlled environments of aquariums, and culture of sponge cells and primmorphs. Cultivation in the sea and aquariums are currently the only practicable and relatively inexpensive methods of producing significant quantities of sponge biomass. In the future, metabolite production from cultured sponge cells and primmorphs may become feasible. Obtaining a consistent biomass yield in aquariums requires attention to many factors that are discussed in this work.

Entities:  

Mesh:

Year:  2003        PMID: 14516872     DOI: 10.1016/s0734-9750(03)00100-9

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  33 in total

1.  Monitoring microbial community composition by fluorescence in situ hybridization during cultivation of the marine cold-water sponge Geodia barretti.

Authors:  Friederike Hoffmann; Hans Tore Rapp; Joachim Reitner
Journal:  Mar Biotechnol (NY)       Date:  2006-06-12       Impact factor: 3.619

Review 2.  Sponge-associated microorganisms: evolution, ecology, and biotechnological potential.

Authors:  Michael W Taylor; Regina Radax; Doris Steger; Michael Wagner
Journal:  Microbiol Mol Biol Rev       Date:  2007-06       Impact factor: 11.056

Review 3.  A functional approach to transcriptome profiling: linking gene expression patterns to metabolites that matter.

Authors:  Cindi A Hoover; Marc Slattery; Adam G Marsh
Journal:  Mar Biotechnol (NY)       Date:  2007-05-01       Impact factor: 3.619

4.  Heliomycin and tetracinomycin D: anthraquinone derivatives with histone deacetylase inhibitory activity from marine sponge-associated Streptomyces sp. SP9.

Authors:  Mohamed Saleh Abdelfattah; Mohammed Ismail Youssef Elmallah; Ahmed Hassan Ibrahim Faraag; Ali Mohamed Salah Hebishy; Neama Hassan Ali
Journal:  3 Biotech       Date:  2018-06-01       Impact factor: 2.406

5.  Marine-based cultivation of diacarnus sponges and the bacterial community composition of wild and maricultured sponges and their larvae.

Authors:  Oded Bergman; Markus Haber; Boaz Mayzel; Matthew A Anderson; Muki Shpigel; Russell T Hill; Micha Ilan
Journal:  Mar Biotechnol (NY)       Date:  2011-05-26       Impact factor: 3.619

6.  Mechanism of cytotoxic action of crambescidin-816 on human liver-derived tumour cells.

Authors:  J A Rubiolo; H López-Alonso; M Roel; M R Vieytes; O Thomas; E Ternon; F V Vega; L M Botana
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 7.  Marine drugs from sponge-microbe association--a review.

Authors:  Tresa Remya A Thomas; Devanand P Kavlekar; Ponnapakkam A LokaBharathi
Journal:  Mar Drugs       Date:  2010-04-22       Impact factor: 5.118

Review 8.  Microtubule-stabilizing drugs from marine sponges: focus on peloruside A and zampanolide.

Authors:  John H Miller; A Jonathan Singh; Peter T Northcote
Journal:  Mar Drugs       Date:  2010-03-31       Impact factor: 5.118

Review 9.  Antiviral lead compounds from marine sponges.

Authors:  Sunil Sagar; Mandeep Kaur; Kenneth P Minneman
Journal:  Mar Drugs       Date:  2010-10-11       Impact factor: 5.118

10.  Culture of explants from the sponge Mycale cecilia to obtain bioactive mycalazal-type metabolites.

Authors:  Jose L Carballo; Benjamin Yañez; Eva Zubía; Maria J Ortega; Cristina Vega
Journal:  Mar Biotechnol (NY)       Date:  2009-11-26       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.